Imaging and analyzing blood clots in the brain

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study utilizes high-resolution MR vessel wall imaging to examine patients with cerebral and cervical artery occlusions. The goal is to investigate how the appearance of thrombus on imaging correlates with the outcomes of recanalization treatments. By understanding these relationships, the study aims to address challenges in thrombus characteristics and improve prevention strategies for cerebrovascular diseases. Participants will undergo imaging to help identify potential biomarkers for arterial thrombophilia.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥ 18 years
* Extracranial and/or intracranial artery occlusion confirmed by angiography
* Available for magnetic resonance high-resolution vessel wall imaging
* Written informed consent obtained

Exclusion Criteria:

* Extracranial and/or intracranial artery mild to moderate stenosis
* Pregnant women
* Restenosis or occlusion after artery stenting placement

Where it's running

• Chinese PLA General Hospital
  Beijing, Beijing Municipality, China Recruiting

Study contacts

• Study coordinator: Jinhao Lyu, M.D.
• Email: 330322990@qq.com
• Phone: +8615903562929

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• GPIIb/IIIa PET/CT Imaging for Thrombi in the Brain and Body

  This study tests an imaging tracer called 18F/68Ga-GP1 to see if it safely helps identify thrombi in adults who might have them.

  Recruiting at 3 sites Tianjin Medical University · Hefei, Anhui and 2 other locations · NCT07813559

• Thromboelastometry to Predict Thrombosis and Survival in Glial Tumor Surgery

  Aimed at people with glial tumors undergoing surgery, the study tests whether thromboelastometry and other blood tests can predict blood-clot risk and survival.

  Recruiting Fundacion Clinic per a la Recerca Biomédica · Barcelona · NCT07813377

• Personalized blood-thinner plan for leg artery disease after repair

  A personalized plan using a blood test to tailor antiplatelet therapy is being tested against standard treatment in adults with PAD after a procedure to restore blood flow.

  Recruiting at 2 sites Massachusetts General Hospital · Boston, Massachusetts and 1 other locations · NCT07613840

• Multi-omics search for clotting and bleeding markers in coronary heart disease

  This project will test whether combining proteins, metabolites, genes, sugar tags, and heart images can better predict clotting and major bleeding in people with coronary heart disease on dual antiplatelet therapy.

  Recruiting at 3 sites Chinese Academy of Medical Sciences, Fuwai Hospital · Zhengzhou, Henan and 2 other locations · NCT07523880

• Gruticibart to Prevent Catheter-Related Blood Clots

  This phase II trial tests whether a single dose of gruticibart can prevent blood clots caused by a central venous catheter in adults.

  Recruiting Phase 2 OHSU Knight Cancer Institute · Portland, Oregon · NCT07498517

• Apixaban vs Warfarin in HeartMate 3 LVAD Patients

  This study tests whether apixaban can replace warfarin to prevent clots and bleeding problems in adults with an implanted HeartMate 3 LVAD for at least 3 months.

  Recruiting Phase 3 Columbia University · New York, New York · NCT07471139

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.